4D Molecular Therapeutics Inc.
FDMT | NASDAQ
$15.90
+$0.66 (+4.33%)
Sep 22, 2026, 12:16 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 88.23M | 88.24M | 85.21M | 120K | 33K | 23K | 37K | 17K | 20.22M | 20.45M | 20.72M | 21.99M | 2.28M | 2.21M | 3.13M | 1.97M | 2.84M | 17.26M | 18.04M | 16.97M | 23.02M | 12.08M |
Cost of Revenue | 51.27M | 99.22M | 137.87M | 137.67M | 128.92M | 112.83M | 100M | 124.24M | 110.82M | 102.55M | 97.09M | 92.56M | 86.44M | 83.27M | 80.24M | 76.27M | 73.17M | 67.97M | 61.36M | 56.44M | 52.15M | 52.65M |
Gross Profit | 36.95M | -10.98M | -52.66M | -137.55M | -128.89M | -112.8M | -99.96M | -124.23M | -90.61M | -82.1M | -76.37M | -70.57M | -84.15M | -81.07M | -77.12M | -74.3M | -70.33M | -50.72M | -43.32M | -39.47M | -29.13M | -40.57M |
Operating Income | -197.12M | -179.55M | -159.55M | -230.38M | -220.33M | -203.33M | -187.84M | -168.38M | -131.22M | -120.9M | -112.87M | -104.94M | -117.46M | -113.75M | -110.03M | -106.08M | -102.24M | -81.41M | -71.33M | -66.99M | -52.15M | -59.7M |
Interest Income | 18.15M | 18.76M | 19.48M | 21.24M | 24.2M | 26.89M | 27.05M | 24.96M | 21.55M | 16.51M | 12.21M | 9.17M | 6.09M | 3.92M | 2.57M | 1.24M | 875K | 542K | 449K | 453K | 22K | 29K |
Pretax Income | -179.18M | -160.9M | -140.11M | -209.18M | -196.14M | -176.44M | -160.87M | -143.48M | -109.89M | -104.56M | -100.84M | -95.93M | -111.37M | -109.84M | -107.49M | -105.2M | -101.75M | -81.25M | -71.32M | -66.78M | -52.37M | -59.94M |
Net Income | -179.18M | -160.9M | -140.11M | -209.18M | -196.14M | -176.44M | -160.87M | -143.48M | -109.89M | -104.56M | -100.84M | -95.93M | -111.37M | -109.84M | -107.49M | -105.2M | -101.75M | -81.25M | -71.32M | -66.78M | -52.37M | -59.94M |
Selling & General & Admin | 48.82M | 47.81M | 49.06M | 50.92M | 51.73M | 50.82M | 48.17M | 44.15M | 40.61M | 38.8M | 36.5M | 34.36M | 33.31M | 32.68M | 32.92M | 31.78M | 31.91M | 30.7M | 28.01M | 27.52M | 23.02M | 19.13M |
Research & Development | 240.31M | 219.98M | 195.7M | 181.17M | 170.22M | 154.13M | 141.3M | 124.24M | 110.82M | 102.55M | 97.09M | 92.56M | 86.44M | 83.27M | 80.24M | 76.27M | 73.17M | 67.97M | 61.36M | 56.44M | 52.15M | 52.65M |
Other Expenses | -51.27M | -99.22M | -137.87M | -139.27M | -130.51M | -114.42M | -101.59M | -124.24M | -110.82M | -102.55M | -97.09M | -92.56M | -86.44M | -83.27M | -80.24M | -76.27M | -73.17M | -67.97M | -61.36M | -56.44M | -52.15M | -52.65M |
Operating Expenses | 237.85M | 168.56M | 106.89M | 92.83M | 91.44M | 90.52M | 87.88M | 44.15M | 40.61M | 38.8M | 36.5M | 34.36M | 33.31M | 32.68M | 32.92M | 31.78M | 31.91M | 30.7M | 28.01M | 27.52M | 23.02M | 19.13M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 312K | 312K | 312K | 312K | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | 1.59M | 1.59M | 1.59M | 1.59M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 208.32M | 267.79M | 244.76M | 230.5M | 220.36M | 203.35M | 187.88M | 168.39M | 151.44M | 141.35M | 133.59M | 126.92M | 119.74M | 115.95M | 113.16M | 108.05M | 105.08M | 98.67M | 89.37M | 83.96M | 75.17M | 71.78M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 70.27M | 68.06M | 57.93M | 56.13M | 55.93M | 55.74M | 53.94M | 55.55M | 55.28M | 49.27M | 39.13M | 42.26M | 38.34M | 32.72M | 32.49M | 32.39M | 32.28M | 32.23M | 27.02M | 27.02M | 26.74M | 26.69M |
Shares Outstanding (Diluted) | 70.27M | 68.06M | 57.93M | 56.13M | 55.93M | 55.74M | 53.94M | 55.55M | 55.28M | 49.27M | 39.13M | 42.26M | 38.34M | 32.72M | 32.49M | 32.39M | 32.32M | 32.23M | 27.02M | 27.02M | 26.74M | 26.69M |
EPS (Basic) | -2.72 | -2.66 | -2.51 | -3.75 | -3.53 | -3.18 | -2.98 | -2.91 | -2.36 | -2.50 | -2.67 | -2.68 | -3.18 | -3.26 | -3.24 | -3.33 | -3.41 | -2.84 | -2.64 | -2.48 | -2.02 | -2.76 |
EPS (Diluted) | -2.72 | -2.66 | -2.51 | -3.75 | -3.53 | -3.18 | -2.98 | -2.91 | -2.36 | -2.50 | -2.67 | -2.68 | -3.18 | -3.26 | -3.24 | -3.33 | -3.41 | -2.84 | -2.64 | -2.48 | -2.02 | -2.76 |
EBITDA | -186.96M | -163.43M | -142.94M | -203.21M | -189.74M | -170M | -155.01M | -138.31M | -105.43M | -100.21M | -96.63M | -91.82M | -107.73M | -106.81M | -105.09M | -103.11M | -99.79M | -79.39M | -69.39M | -65.06M | -50.65M | -58.22M |
EBIT | -115.23M | -169.89M | -149.1M | -209.18M | -196.14M | -176.44M | -160.87M | -143.48M | -109.89M | -104.56M | -100.84M | -95.93M | -111.37M | -109.84M | -107.49M | -104.89M | -101.43M | -80.94M | -70.91M | -66.56M | -52.14M | -59.7M |
Depreciation & Amortization | 5.3M | 6.46M | 6.16M | 5.97M | 6.41M | 6.44M | 5.85M | 5.17M | 4.46M | 4.35M | 4.2M | 4.12M | 3.64M | 3.03M | 2.4M | 1.78M | 1.64M | 1.55M | 1.52M | 1.5M | 1.49M | 1.48M |
Add to Watchlist
Select watchlists to add or remove FDMT